Metraipolis › archive › dc_7c52884238e4
Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering — Europe PMC PMID:40857086
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40857086
- DOI
- 10.1021/acsnano.5c10267
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:56:32.430Z
- SHA-256 of the archived text
367f65ea525390dad2d0be5fe6e45b4dce5ad530190ae0372eeeb9f2f0ab76bb- Stable URL of this page
https://metraipolis.com/documento/dc_7c52884238e4
How to cite
Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering — Europe PMC PMID:40857086 — Europe PMC (en), https://europepmc.org/article/MED/40857086 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c52884238e4 (Metraipolis archive dc_7c52884238e4, sha256 367f65ea525390dad2d0be5fe6e45b4dce5ad530190ae0372eeeb9f2f0ab76bb)
BibTeX
@misc{dc7c52884238e4,
title = {Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering — Europe PMC PMID:40857086},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40857086},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c52884238e4; sha256 367f65ea525390dad2d0be5fe6e45b4dce5ad530190ae0372eeeb9f2f0ab76bb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40857086. Agents can read the archived copy with the MCP tool read_document.